secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2026-08-19T22:36:37+00:00
Accession:  0001193125-26-357258
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica stockholders approve reverse split, 7.5M-share plan increase, warrant issuances
--------------------------------------------------------------------------------

- Approved reverse stock split at ratio between 1-for-2 and 1-for-10, with corresponding reduction in authorized shares; board to set timing and ratio.
- Equity plan amended to increase shares by 7,500,000; annual auto reserve now includes shares from convertible preferred and pre-funded warrants.
- Elected Allan Shaw and Robert N. Wilson as Class III directors for three-year terms.
- Approved issuance of up to 18,673,429 shares under Series A/B warrants (Rule 5635(d)) and 1,680,565 each for officers/directors (Rule 5635(c)).
- Say-on-pay advisory vote passed; frequency of one year, with next vote no later than 2032 annual meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312526357258/0001193125-26-357258-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312526357258/d434771d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-357258

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer